Crystalvue Medical Co Ltd Statistics
Crystalvue Medical Co Ltd (6527) Stock Statistics & Valuation Metrics
Total Valuation
Crystalvue Medical Co Ltd has a market cap or net worth of TWD 1.81B. The enterprise value is TWD 1.82B.
- Market Cap
- TWD 1.81B
- Enterprise Value
- TWD 1.82B
Share Statistics
Crystalvue Medical Co Ltd has 25,458,550 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 25,458,550
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Crystalvue Medical Co Ltd’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 14.27%.
- Return on Equity (ROE)
- 0.14
- Return on Assets (ROA)
- 0.11
- Return on Invested Capital (ROIC)
- 14.27%
- Return on Capital Employed (ROCE)
- 0.17
- Revenue Per Employee
- 8.71M
- Profits Per Employee
- 1.35M
- Employee Count
- 109
- Asset Turnover
- 0.73
- Inventory Turnover
- 2.43
Valuation Ratios
The current PE Ratio of Crystalvue Medical Co Ltd is 12.26. Crystalvue Medical Co Ltd’s PEG ratio is 1.23.
- PE Ratio
- 12.26
- PS Ratio
- 2.10
- PB Ratio
- 1.82
- Price to FCF
- -45.77
- Price to Operating Cash Flow
- 11.65
- PEG Ratio
- 1.23
Income Statement
In the last 12 months, Crystalvue Medical Co Ltd had revenue of 949.05M and earned 146.98M in profits. Earnings per share was 5.80.
- Revenue
- 949.05M
- Gross Profit
- 331.88M
- Operating Income
- 180.94M
- Pretax Income
- 179.01M
- Net Income
- 146.98M
- EBITDA
- 198.76M
- Earnings Per Share (EPS)
- 5.80
Cash Flow
In the last 12 months, operating cash flow was 161.19M and capital expenditures -202.27M, giving a free cash flow of -41.08M billion.
- Operating Cash Flow
- 161.19M
- Free Cash Flow
- -41.08M
- Free Cash Flow per Share
- -1.62
Dividends & Yields
Crystalvue Medical Co Ltd pays an annual dividend of ―, resulting in a dividend yield of 4.02%
- Dividend Per Share
- ―
- Dividend Yield
- 4.02%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.18%
- Earnings Yield
- 8.17%
Stock Price Statistics
- Beta
- 0.21
- 52-Week Price Change
- -12.07%
- 50-Day Moving Average
- 73.81
- 200-Day Moving Average
- 70.70
- Relative Strength Index (RSI)
- 44.32
- Average Volume (3m)
- 18.55K
Important Dates
Crystalvue Medical Co Ltd upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Crystalvue Medical Co Ltd as a current ratio of 2.45, with Debt / Equity ratio of 1.14%
- Current Ratio
- 2.45
- Quick Ratio
- 1.48
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.61
- Interest Coverage Ratio
- 399.44
Taxes
In the past 12 months, Crystalvue Medical Co Ltd has paid 32.03M in taxes.
- Income Tax
- 32.03M
- Effective Tax Rate
- 0.18
Enterprise Valuation
Crystalvue Medical Co Ltd EV to EBITDA ratio is 9.82, with an EV/FCF ratio of -44.66.
- EV to Sales
- 2.05
- EV to EBITDA
- 9.82
- EV to Free Cash Flow
- -44.66
- EV to Operating Cash Flow
- 11.38
Balance Sheet
Crystalvue Medical Co Ltd has TWD 84.02M in cash and marketable securities with TWD 38.25M in debt, giving a net cash position of TWD 45.76M billion.
- Cash & Marketable Securities
- TWD 84.02M
- Total Debt
- TWD 38.25M
- Net Cash
- TWD 45.76M
- Net Cash Per Share
- TWD 1.80
- Tangible Book Value Per Share
- TWD 40.64
Margins
Gross margin is 38.48%, with operating margin of 20.21%, and net profit margin of 17.15%.
- Gross Margin
- 38.48%
- Operating Margin
- 20.21%
- Pretax Margin
- 21.20%
- Net Profit Margin
- 17.15%
- EBITDA Margin
- 20.89%
- EBIT Margin
- 20.21%
Analyst Forecast
The average price target for Crystalvue Medical Co Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -1.23%
- EPS Growth Forecast
- 10.20%
